Table 1 |
|||
|
Clinical profiles of subjects |
|||
|
Profiles |
GDM |
Controls |
P value |
|
|
|||
|
Number of subjects |
928 |
990 |
|
|
Age(yr) |
33.17 (22-52) |
32.24 (23-44) |
<0.0001 |
|
Mean gestation week (wk) |
26.03 ± 2.69 |
26.12 ± 1.69 |
0.37 |
|
BMI(kg/m2) |
23.32 ± 4.01 |
21.40 ± 2.93 |
<0.0001 |
|
AUC-G (Area under glucose curve) |
482.46 ± 57.04 |
358.72 ± 39.99 |
<0.0001 |
|
HOMA-B (Homeostatic model assessment, β-cell function) |
208.06 ± 112.75 |
268.30 ± 179.88 |
<0.0001 |
|
HOMA-IR (Homeostatic model assessment, insulin resistance) |
3.07 ± 1.76 |
2.14 ± 1.02 |
<0.0001 |
|
Fasting plasma insulin (pmol/liter) |
13.51 ± 6.62 |
10.82 ± 4.72 |
<0.0001 |
|
Fasting plasma glucose (pmol/liter) |
89.95 ± 13.72 |
79.31 ± 6.11 |
<0.0001 |
|
|
|||
|
Data are presented as means ± standard deviation except age. Data are presented as SD. |
|||
|
Kim et al. BMC Medical Genetics 2011 12:82 doi:10.1186/1471-2350-12-82 |
|||